Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc.

PVLA
Palvella Therapeutics, Inc.US flagNASDAQ Global Market
143.94
USD
+19.79
- -
1.70BMarket Cap

Income Statement (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- Operating Expenses
18
12
14
39
+ Selling, General & Admin
4
3
6
16
+ Research & Development
14
9
8
23
+ Other Operating Expense
- -
- -
- -
- -
Operating Income (Loss)
-18
-12
-14
-39
- Non-Operating (Income) Loss
11
-31
3
3
+ Interest Expense, Net
- -
-6
4
3
+ Interest Expense
- -
- -
4
6
- Interest Income
- -
6
1
3
+ Other Non-Op (Income) Loss
11
-24
- -
- -
Pretax Income
-29
19
-17
-42
- Income Tax Expense (Benefit)
-1
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
Income (Loss) from Cont Ops
-28
19
-17
-42
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
Income (Loss) Incl. MI
-28
19
-17
-42
- Minority Interest
- -
- -
- -
- -
Net Income, GAAP
-28
19
-17
-42
- Preferred Dividends
- -
1
- -
- -
- Other Adjustments
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-28
18
-17
-42
EBIT
-18
-12
-14
-39
EBITDA
-18
-12
-14
-39
EBITDA Margin (%)
- -
- -
- -
- -
EBITA
-18
-12
-14
-39
Gross Margin (%)
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
Basic Weighted Avg Shares
11
11
2
11
Basic EPS, GAAP
-2.46
1.6
-7.83
-3.71
Basic EPS from Cont Ops
-2.46
1.67
-7.83
-3.71
Diluted Weighted Avg Shares
11
11
2
11
Diluted EPS, GAAP
-2.46
1.6
-7.83
-3.71
Diluted EPS from Cont Ops
-2.46
1.67
-7.83
-3.71

Balance Sheet (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
17
8
88
59
+ Cash, Cash Equivalents & STI
16
7
84
58
+ Cash & Cash Equivalents
16
7
84
58
+ ST Investments
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
2
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
2
- -
+ Inventories
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
+ Other ST Assets
- -
- -
2
1
+ Misc ST Assets
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
- -
1
+ Property, Plant & Equip, Net
- -
- -
- -
1
+ Property, Plant & Equip
- -
- -
- -
1
- Accumulated Depreciation
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
Total Assets
17
8
88
60
+ Payables & Accruals
5
2
6
6
+ Accounts Payable
3
1
5
5
+ Accrued Taxes
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
+ Other Payables & Accruals
2
1
1
2
+ ST Debt
- -
- -
- -
- -
+ ST Borrowings
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
+ Other ST Liabilities
1
- -
6
5
+ Deferred Revenue
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Misc ST Liabilities
1
- -
6
5
Total Current Liabilities
6
2
12
11
+ LT Debt
- -
- -
- -
- -
+ LT Borrowings
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
+ Other LT Liabilities
34
9
14
20
+ Accrued Liabilities
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Misc LT Liabilities
34
9
14
20
Total Noncurrent Liabilities
34
9
14
20
Total Liabilities
40
11
26
32
+ Preferred Equity and Hybrid Capital
71
71
- -
- -
+ Share Capital & APIC
1
2
156
163
+ Common Stock
- -
- -
- -
- -
+ Additional Paid in Capital
1
2
156
163
- Treasury Stock
- -
- -
- -
- -
+ Retained Earnings
-95
-76
-94
-135
+ Other Equity
- -
- -
- -
- -
Equity Before Minority Interest
-23
-4
63
28
+ Minority/Non Controlling Interest
- -
- -
- -
- -
Total Equity
-23
-4
63
28
Total Liabilities & Equity
17
8
88
60
Shares Outstanding
11
11
11
12
Number of Employees
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
1
Net Debt
-16
-7
-84
-58
Net Debt to Equity
69.27
189.43
-133.53
-207.2
Tangible Common Equity Ratio
-567.52
-986.79
70.96
46.98
Current Ratio
2.86
3.2
7.33
5.2
Cash Conversion Cycle
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-28
19
-17
-42
+ Depreciation & Amortization
- -
- -
- -
- -
+ Non-Cash Items
11
-29
7
13
+ Stock-Based Compensation
- -
1
1
6
+ Deferred Income Taxes
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
+ Other Non-Cash Adj
11
-30
6
6
+ Chg in Non-Cash Work Cap
2
-3
- -
4
+ (Inc) Dec in Accts Receiv
- -
- -
-2
2
+ (Inc) Dec in Inventories
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
1
- -
-2
1
+ Inc (Dec) in Accts Payable
1
-3
3
- -
+ Inc (Dec) in Other
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Operating Activities
-15
-14
-11
-25
+ Change in Fixed & Intang
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
- -
+ Increase in Capital Stock
- -
- -
- -
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
+ Dividends Paid
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
78
- -
+ Cash From Debt
- -
- -
78
- -
+ Repayments of Debt
- -
- -
- -
- -
+ Other Financing Activities
10
5
9
-1
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Financing Activities
10
5
87
-1
Effect of Foreign Exchange Rates
- -
- -
- -
- -
Net Changes in Cash
-5
-9
76
-26
EBITDA
-18
-12
-14
-39
EBITDA Margin (%)
- -
- -
- -
- -
Free Cash Flow
-15
-14
-11
-25
Net Cash Paid for Acquisitions
- -
- -
- -
- -
Free Cash Flow to Firm
- -
-14
- -
- -
Free Cash Flow to Equity
- -
-14
-3
-25
Free Cash Flow per Basic Share
-1.32
-1.22
-4.87
-2.22
Price/Free Cash Flow
- -
- -
-2.46
-47.1
Cash Flow to Net Income
0.54
-0.73
0.62
0.6
Capital Expenditures
- -
- -
- -
- -